IlluMyFi

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) – Research analysts at HC Wainwright issued their FY2024 earnings per share estimates for Corvus Pharmaceuticals in a research note issued on Thursday, January 2nd. HC Wainwright analyst S. Lee anticipates that the company will post earnings per share of ($0.41) for the year. HC Wainwright has a [...]

Sentiment

0.34

Bearish/Bullish

06.01.25 04:14

by americanbankingnews.com

PACS Group (NYSE:PACS) Price Target Cut to $24.00 by Analysts at Macquarie

PACS Group (NYSE:PACS – Get Free Report) had its price target dropped by Macquarie from $42.00 to $24.00 in a research note issued on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Macquarie’s price objective suggests a potential upside of 77.12% from the company’s previous close. PACS has been the topic [...]

United States of America